Annual report pursuant to Section 13 and 15(d)

Segment Reporting

v3.3.0.814
Segment Reporting
 12 Months Ended
Jun. 30, 2015
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
17.
Segment Reporting
 
As discussed above, iBio Brazil began operations in the first quarter of fiscal 2015. In accordance with FASB ASC 280, “Segment Reporting,” the Company discloses financial and descriptive information about its reportable geographic segments. Geographic segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.
 
 
 
 
 
iBio
 
 
 
Year ended June 30, 2015
 
iBio
 
Brazil
 
Total
 
 
 
 
 
 
 
 
 
Net revenues
 
$
1,851
 
$
-
 
$
1,851
 
Research and development expenses
 
 
3,495
 
 
-
 
 
3,495
 
General and administrative expenses
 
 
4,929
 
 
93
 
 
5,022
 
Operating loss
 
 
(6,573)
 
 
(93)
 
 
(6,666)
 
Total assets
 
 
12,448
 
 
46
 
 
12,494